NORTH CHINA PHARMACEUTICAL COMPANY. LTD

The company's predecessor, the North China Pharmaceutical Factory, was a key construction project during China's “First Five-Year Plan”. Preparation began in June 1953, and was completed and put into operation in June 1958. It pioneered the history of large-scale antibiotic production in China, and made important contributions to the cause of human health, the development of the national pharmaceutical industry, and the shortage of medicines in China. The company was restructured in 1992 and listed on the Shanghai Stock Exchange in 1994. It is mainly engaged in R&D, production and sales of pharmaceutical products. The company's products cover the fields of chemical pharmaceuticals, modern biotechnological drugs, vitamins and health consumer products, biological pesticides and veterinary drugs, etc., covering more than 700 products such as anti-infective drugs, biotechnological drugs, cardiovascular and immunomodulators, vitamins and health consumer products. Corporate honors: 2017 - North China Pharmaceutical Group won the top ten export companies in China's Western Pharmaceutical Industry, 2016 - North China Pharmaceutical Group won the top ten pharmaceutical industry enterprises in Hebei Province, 2016 - North China Pharmaceutical Group won the top ten pharmaceutical industry enterprises in Hebei Province, 2014 - won the top 100 comprehensive strength industrial enterprises in China's chemical pharmaceutical industry, etc.